Royal Bank of Canada’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,615
| Closed | -$9K | – | 7516 |
|
|
2019
Q1 | $9K | Sell |
1,615
-12,312
| -88% | -$41.9K | ﹤0.01% | 6070 |
|
|
2018
Q4 | $18K | Sell |
13,927
-1,926
| -12% | -$3.35K | ﹤0.01% | 5645 |
|
|
2018
Q3 | $55K | Buy |
15,853
+12,513
| +375% | +$47K | ﹤0.01% | 5191 |
|
|
2018
Q2 | $16K | Buy |
3,340
+107
| +3% | +$426 | ﹤0.01% | 5668 |
|
|
2018
Q1 | $11K | Buy |
3,233
+18
| +0.6% | +$64 | ﹤0.01% | 5702 |
|
|
2017
Q4 | $13K | Buy |
3,215
+1,613
| +101% | +$8.79K | ﹤0.01% | 5781 |
|
|
2017
Q3 | $17K | Buy |
+1,602
| New | +$15.8K | ﹤0.01% | 6054 |
|
|
2017
Q2 | – | Sell |
-630
| Closed | -$4K | – | 7141 |
|
|
2017
Q1 | $4K | Sell |
630
-258
| -29% | -$1.49K | ﹤0.01% | 6323 |
|
|
2016
Q4 | $5K | Buy |
888
+816
| +1,133% | +$5.76K | ﹤0.01% | 6330 |
|
|
2016
Q3 | $1K | Buy |
+72
| New | +$526 | ﹤0.01% | 6359 |
|
|
2016
Q1 | – | Sell |
-31
| Closed | – | – | 7108 |
|
|
2015
Q4 | $0 | Sell |
31
-451
| -94% | -$7.77K | ﹤0.01% | 7247 |
|
|
2015
Q3 | $6K | Sell |
482
-664
| -58% | -$12.4K | ﹤0.01% | 6139 |
|
|
2015
Q2 | $23K | Buy |
+1,146
| New | +$27.1K | ﹤0.01% | 5635 |
|
Royal Bank of Canada's IMDZ Position: Q2 2019 in Review
Royal Bank of Canada sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 1,615 shares — an estimated $9K sold.
Royal Bank of Canada first reported a position in IMDZ in Q2 2015 and held it in 13 quarters. The position peaked at $55K in Q3 2018. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- Royal Bank of Canada reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- Royal Bank of Canada sold 1,615 Immune Design Corp. shares in Q2 2019, an estimated $9K.
- Royal Bank of Canada first reported a position in Immune Design Corp. in Q2 2015 and held it in 13 quarters.
- Royal Bank of Canada's Immune Design Corp. position peaked at $55K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on Royal Bank of Canada's 13F filing for Q2 2019, filed 14 Aug 2019.